Nicole Steinmetz and a team at University of California, San Diego formulated cowpea mosaic virus (CPMV) nanoparticles in injectable hydrogels to achieve slow particle release and prolonged immunostimulation, eliciting an antibody response that was sustained over 20 weeks in mouse models.
Comments